Stoke Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell STOK and other ETFs, options, and stocks.About STOK
Stoke Therapeutics, Inc. is a biotechnology company, which engages in the research and development of treatments for genetic diseases. It offers a wide range of relevant tissues including the central nervous system, eye, kidney, and liver.
CEOIan Frederick Smith
CEOIan Frederick Smith
Employees128
Employees128
HeadquartersBedford, Massachusetts
HeadquartersBedford, Massachusetts
Founded2014
Founded2014
Employees128
Employees128
STOK Key Statistics
Market cap1.94B
Market cap1.94B
Price-Earnings ratio53.30
Price-Earnings ratio53.30
Dividend yield—
Dividend yield—
Average volume632.29K
Average volume632.29K
High today$34.84
High today$34.84
Low today$33.22
Low today$33.22
Open price$34.01
Open price$34.01
Volume109.89K
Volume109.89K
52 Week high$38.69
52 Week high$38.69
52 Week low$5.35
52 Week low$5.35
Stock Snapshot
Stoke Therapeutics(STOK) stock is priced at $33.91, giving the company a market capitalization of 1.94B. It carries a P/E multiple of 53.30.
As of 2026-01-08, Stoke Therapeutics(STOK) stock has fluctuated between $33.22 and $34.84. The current price stands at $33.91, placing the stock +2.1% above today's low and -2.7% off the high.
The Stoke Therapeutics(STOK)'s current trading volume is 109.89K, compared to an average daily volume of 632.29K.
During the past year, Stoke Therapeutics(STOK) stock moved between $5.35 at its lowest and $38.69 at its peak.
During the past year, Stoke Therapeutics(STOK) stock moved between $5.35 at its lowest and $38.69 at its peak.
Analyst ratings
100%
of 10 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own STOK. This list is generated using Robinhood data, and it’s not a recommendation.